首页> 外文会议>Conference on optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy >First experience of photodithazine clinical application for photodynamictherapy of malignant tumors,
【24h】

First experience of photodithazine clinical application for photodynamictherapy of malignant tumors,

机译:噻二嗪临床应用在恶性肿瘤光动力治疗中的初步经验,

获取原文

摘要

Abstract: In 1998 a new second-generation photosensitizer was introduced in Russia - a chlorine derivative named Photodithazine - water-soluble preparation with absorption peak at 668 nm. This novel preparation has passed pre- clinical in vitro and in vivo studies. In 1999 a limited series of clinical testing of photodynamic therapy with photodithazine has been performed in the State Research Center for Laser Medicine of Russian Ministry of Public Health. !11
机译:摘要:1998年,俄罗斯引入了一种新的第二代光敏剂-一种氯衍生物Photodithazine-吸收峰在668 nm的水溶性制剂。这种新颖的制剂已通过临床前的体外和体内研究。在1999年,在俄罗斯公共卫生部激光医学国家研究中心进行了一系列有限的光动力学疗法与光二嗪的临床试验。 !11

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号